Elevance Health EPS (earnings per share) 1998–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Elevance Health's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 6.27 USD, up 17.9% on the same quarter a year before. Elevance Health's diluted earnings per share over the last twelve months were 23.45 USD, down 4.1% on the twelve months before. In fiscal year 2025 they were 25.12 USD, down 2.2% on the year before.
Last updated 12 Nov 2026 · Next report 27 Jan 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 23.45 | -4.13% | 23.48 |
| FY2025 | 31 Dec 2025 | 25.12 | -2.18% | 25.18 |
| FY2024 | 31 Dec 2024 | 25.68 | +1.82% | 25.81 |
| FY2023 | 31 Dec 2023 | 25.22 | +3.87% | 25.38 |
| FY2022 | 31 Dec 2022 | 24.28 | -1.82% | 24.56 |
| FY2021 | 31 Dec 2021 | 24.73 | +37.54% | 25.25 |
| FY2020 | 31 Dec 2020 | 17.98 | -2.65% | 18.23 |
| FY2019 | 31 Dec 2019 | 18.47 | +30.16% | 18.81 |
| FY2018 | 31 Dec 2018 | 14.19 | -1.11% | 14.53 |
| FY2017 | 31 Dec 2017 | 14.35 | +55.81% | 14.70 |
| FY2016 | 31 Dec 2016 | 9.21 | -1.81% | 9.39 |
| FY2015 | 31 Dec 2015 | 9.38 | +4.80% | 9.73 |
| FY2014 | 31 Dec 2014 | 8.95 | +2.40% | 9.31 |
| FY2013 | 31 Dec 2013 | 8.74 | +6.85% | 8.89 |
| FY2012 | 31 Dec 2012 | 8.18 | +12.83% | 8.26 |
| FY2011 | 31 Dec 2011 | 7.25 | +4.47% | 7.80 |
| FY2010 | 31 Dec 2010 | 6.94 | -29.76% | 7.64 |
| FY2009 | 31 Dec 2009 | 9.88 | +107.56% | 9.96 |
| FY2008 | 31 Dec 2008 | 4.76 | -14.39% | 4.79 |
| FY2007 | 31 Dec 2007 | 5.56 | +15.35% | 5.64 |
| FY2006 | 31 Dec 2006 | 4.82 | +22.34% | 4.93 |
| FY2005 | 31 Dec 2005 | 3.94 | +29.18% | 4.03 |
| FY2004 | 31 Dec 2004 | 3.05 | +11.72% | 3.15 |
| FY2003 | 31 Dec 2003 | 2.73 | +20.80% | 2.80 |
| FY2002 | 31 Dec 2002 | 2.26 | +36.97% | 2.31 |
| FY2001 | 31 Dec 2001 | 1.65 | +50.00% | 1.66 |
| FY2000 | 31 Dec 2000 | 1.10 | +400.00% | 1.10 |
| FY1999 | 31 Dec 1999 | 0.22 | -73.81% | 0.22 |
| FY1998 | 31 Dec 1998 | 0.84 | — | 0.84 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 6.27 | +17.86% | 6.30 |
| Q2 FY2026 | 30 Jun 2026 | 6.71 | -13.08% | 6.71 |
| Q1 FY2026 | 31 Mar 2026 | 8.00 | -16.75% | 8.00 |
| Q4 FY2025 | 31 Dec 2025 | 2.47 | +36.46% | 2.47 |
| Q3 FY2025 | 30 Sept 2025 | 5.32 | +22.02% | 5.32 |
| Q2 FY2025 | 30 Jun 2025 | 7.72 | -21.62% | 7.72 |
| Q1 FY2025 | 31 Mar 2025 | 9.61 | +0.21% | 9.64 |
| Q4 FY2024 | 31 Dec 2024 | 1.81 | -50.14% | 1.84 |
| Q3 FY2024 | 30 Sept 2024 | 4.36 | -20.00% | 4.36 |
| Q2 FY2024 | 30 Jun 2024 | 9.85 | +26.44% | 9.91 |
| Q1 FY2024 | 31 Mar 2024 | 9.59 | +15.54% | 9.65 |
| Q4 FY2023 | 31 Dec 2023 | 3.63 | +1.11% | 3.67 |
| Q3 FY2023 | 30 Sept 2023 | 5.45 | -17.67% | 5.48 |
| Q2 FY2023 | 30 Jun 2023 | 7.79 | +15.75% | 7.83 |
| Q1 FY2023 | 31 Mar 2023 | 8.30 | +13.39% | 8.37 |
| Q4 FY2022 | 31 Dec 2022 | 3.59 | -22.46% | 3.64 |
| Q3 FY2022 | 30 Sept 2022 | 6.62 | +7.99% | 6.69 |
| Q2 FY2022 | 30 Jun 2022 | 6.73 | -7.17% | 6.80 |
| Q1 FY2022 | 31 Mar 2022 | 7.32 | +9.09% | 7.41 |
| Q4 FY2021 | 31 Dec 2021 | 4.63 | +111.42% | 4.70 |
| Q3 FY2021 | 30 Sept 2021 | 6.13 | +604.60% | 6.20 |
| Q2 FY2021 | 30 Jun 2021 | 7.25 | -18.63% | 7.33 |
| Q1 FY2021 | 31 Mar 2021 | 6.71 | +12.96% | 6.80 |
| Q4 FY2020 | 31 Dec 2020 | 2.19 | -39.50% | 2.25 |
| Q3 FY2020 | 30 Sept 2020 | 0.87 | -80.88% | 0.88 |
| Q2 FY2020 | 30 Jun 2020 | 8.91 | +104.36% | 9.02 |
| Q1 FY2020 | 31 Mar 2020 | 5.94 | +0.51% | 6.03 |
| Q4 FY2019 | 31 Dec 2019 | 3.62 | +124.84% | 3.69 |
| Q3 FY2019 | 30 Sept 2019 | 4.55 | +25.69% | 4.64 |
| Q2 FY2019 | 30 Jun 2019 | 4.36 | +9.55% | 4.44 |
| Q1 FY2019 | 31 Mar 2019 | 5.91 | +18.44% | 6.03 |
| Q4 FY2018 | 31 Dec 2018 | 1.61 | -65.52% | 1.65 |
| Q3 FY2018 | 30 Sept 2018 | 3.62 | +29.29% | 3.70 |
| Q2 FY2018 | 30 Jun 2018 | 3.98 | +25.95% | 4.07 |
| Q1 FY2018 | 31 Mar 2018 | 4.99 | +33.78% | 5.13 |
| Q4 FY2017 | 31 Dec 2017 | 4.67 | +240.88% | 4.80 |
| Q3 FY2017 | 30 Sept 2017 | 2.80 | +21.74% | 2.87 |
| Q2 FY2017 | 30 Jun 2017 | 3.16 | +8.59% | 3.23 |
| Q1 FY2017 | 31 Mar 2017 | 3.73 | +41.83% | 3.82 |
| Q4 FY2016 | 31 Dec 2016 | 1.37 | +101.47% | 1.40 |
| Q3 FY2016 | 30 Sept 2016 | 2.30 | -5.35% | 2.35 |
| Q2 FY2016 | 30 Jun 2016 | 2.91 | -7.03% | 2.97 |
| Q1 FY2016 | 31 Mar 2016 | 2.63 | -14.89% | 2.67 |
| Q4 FY2015 | 31 Dec 2015 | 0.68 | -62.22% | 0.69 |
| Q3 FY2015 | 30 Sept 2015 | 2.43 | +9.46% | 2.51 |
| Q2 FY2015 | 30 Jun 2015 | 3.13 | +22.27% | 3.27 |
| Q1 FY2015 | 31 Mar 2015 | 3.09 | +28.75% | 3.25 |
| Q4 FY2014 | 31 Dec 2014 | 1.80 | +252.94% | 1.90 |
| Q3 FY2014 | 30 Sept 2014 | 2.22 | +2.78% | 2.33 |
| Q2 FY2014 | 30 Jun 2014 | 2.56 | -3.03% | 2.66 |
| Q1 FY2014 | 31 Mar 2014 | 2.40 | -16.96% | 2.49 |
| Q4 FY2013 | 31 Dec 2013 | 0.51 | -66.45% | 0.53 |
| Q3 FY2013 | 30 Sept 2013 | 2.16 | +0.47% | 2.22 |
| Q2 FY2013 | 30 Jun 2013 | 2.64 | +36.08% | 2.67 |
| Q1 FY2013 | 31 Mar 2013 | 2.89 | +14.23% | 2.92 |
| Q4 FY2012 | 31 Dec 2012 | 1.52 | +53.54% | 1.53 |
| Q3 FY2012 | 30 Sept 2012 | 2.15 | +13.16% | 2.20 |
| Q2 FY2012 | 30 Jun 2012 | 1.94 | +2.65% | 1.96 |
| Q1 FY2012 | 31 Mar 2012 | 2.53 | +3.69% | 2.58 |
| Q4 FY2011 | 31 Dec 2011 | 0.99 | -31.72% | 1.01 |
| Q3 FY2011 | 30 Sept 2011 | 1.90 | +3.26% | 1.92 |
| Q2 FY2011 | 30 Jun 2011 | 1.89 | +11.83% | 1.92 |
| Q1 FY2011 | 31 Mar 2011 | 2.44 | +24.49% | 2.51 |
| Q4 FY2010 | 31 Dec 2010 | 1.45 | -76.38% | 1.49 |
| Q3 FY2010 | 30 Sept 2010 | 1.84 | +20.26% | 1.87 |
| Q2 FY2010 | 30 Jun 2010 | 1.69 | +18.18% | 1.73 |
| Q1 FY2010 | 31 Mar 2010 | 1.96 | +68.97% | 1.99 |
| Q4 FY2009 | 31 Dec 2009 | 6.14 | +816.42% | 6.22 |
| Q3 FY2009 | 30 Sept 2009 | 1.53 | -4.38% | 1.55 |
| Q2 FY2009 | 30 Jun 2009 | 1.43 | -0.69% | 1.44 |
| Q1 FY2009 | 31 Mar 2009 | 1.16 | +8.41% | 1.17 |
| Q4 FY2008 | 31 Dec 2008 | 0.67 | -57.05% | 0.67 |
| Q3 FY2008 | 30 Sept 2008 | 1.60 | +10.34% | 1.60 |
| Q2 FY2008 | 30 Jun 2008 | 1.44 | +6.67% | 1.44 |
| Q1 FY2008 | 31 Mar 2008 | 1.07 | -15.08% | 1.08 |
| Q4 FY2007 | 31 Dec 2007 | 1.56 | +20.93% | 1.58 |
| Q3 FY2007 | 30 Sept 2007 | 1.45 | +12.40% | 1.47 |
| Q2 FY2007 | 30 Jun 2007 | 1.35 | +15.38% | 1.37 |
| Q1 FY2007 | 31 Mar 2007 | 1.26 | +15.60% | 1.28 |
| Q4 FY2006 | 31 Dec 2006 | 1.29 | +32.99% | 1.31 |
| Q3 FY2006 | 30 Sept 2006 | 1.29 | +26.47% | 1.31 |
| Q2 FY2006 | 30 Jun 2006 | 1.17 | +30.00% | 1.20 |
| Q1 FY2006 | 31 Mar 2006 | 1.09 | +11.22% | 1.12 |
| Q4 FY2005 | 31 Dec 2005 | 0.97 | +223.33% | 1.00 |
| Q3 FY2005 | 30 Sept 2005 | 1.02 | +20.00% | 1.05 |
| Q2 FY2005 | 30 Jun 2005 | 0.90 | +8.43% | 0.92 |
| Q1 FY2005 | 31 Mar 2005 | 0.98 | -8.41% | 1.01 |
| Q4 FY2004 | 31 Dec 2004 | 0.30 | -58.90% | 0.30 |
| Q3 FY2004 | 30 Sept 2004 | 0.85 | +23.19% | 0.87 |
| Q2 FY2004 | 30 Jun 2004 | 0.83 | +31.75% | 0.86 |
| Q1 FY2004 | 31 Mar 2004 | 1.07 | +57.35% | 1.12 |
| Q4 FY2003 | 31 Dec 2003 | 0.73 | +19.67% | 0.76 |
| Q3 FY2003 | 30 Sept 2003 | 0.69 | +6.15% | 0.71 |
| Q2 FY2003 | 30 Jun 2003 | 0.63 | +23.53% | 0.64 |
| Q1 FY2003 | 31 Mar 2003 | 0.68 | +41.67% | 0.69 |
| Q4 FY2002 | 31 Dec 2002 | 0.61 | +45.24% | 0.62 |
| Q3 FY2002 | 30 Sept 2002 | 0.65 | +20.37% | 0.67 |
| Q2 FY2002 | 30 Jun 2002 | 0.51 | — | 0.52 |
| Q1 FY2002 | 31 Mar 2002 | 0.48 | — | 0.49 |
| Q4 FY2001 | 31 Dec 2001 | 0.42 | — | 0.43 |
| Q3 FY2001 | 30 Sept 2001 | 0.54 | — | 0.54 |
| Q1 FY2001 | 31 Mar 2001 | 0.00 | — | 0.00 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Elevance Health's EPS
Source: Financial Modeling Prep
